AirSculpt Technologies vs LifeMD
LifeMD reported revenue of $194 million in fiscal 2025, 1.3 times AirSculpt Technologies' $152 million in fiscal 2025. AirSculpt Technologies' revenue fell 15.8% in its latest year, and LifeMD's grew 25.3%. AirSculpt Technologies had an operating margin of -7.6%, against -4.0% at LifeMD. Free cash flow was $1 million at AirSculpt Technologies and $6 million at LifeMD.
Side by side
| AirSculpt Technologies | LifeMD | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $152M | $194M |
| Revenue growth | −15.8% | 25.3% |
| Revenue growth a year, last 5 years | 19.3% | 39.1% |
| Gross margin | — | 85.7% |
| Operating margin | −7.6% | −4.0% |
| Net margin | −7.7% | 7.4% |
| Free cash flow | $1M | $6M |
| Free cash flow margin | 0.5% | 3.3% |
| Return on capital | −6.6% | — |
| Net debt to EBITDA | 39.0x | — |
| Dividends and buybacks | $0M | $3M |
| Change in diluted share count | 4.8% | 9.6% |
| Last close | $0.65 | $1.59 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $2.0 million, sold $0 | sold $54,150 |
| Piotroski F-score | 3 of 8 | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
AirSculpt TechnologiesLifeMD
Operating margin
Percent of revenue
AirSculpt TechnologiesLifeMD
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AirSculpt TechnologiesLifeMD
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the AirSculpt Technologies and LifeMD pages.